Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
68 participants
INTERVENTIONAL
2012-11-30
2013-12-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Immediate Effects of Dry Needling and Tens in Chronic Neck Pain
NCT02230709
Dry Needling Dosage in the Treatment of Myofascial Neck Pain
NCT02190890
The Effects of Dry Needling on the Superficial Neck Musculature
NCT04060004
Neurophysiological Effects of Dry Needling in Patients With Neck Pain
NCT03345238
Dry Needling Versus Intramuscular Stimulation in the Management of the Myofascial Trigger Points
NCT03025230
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
dry needling and TENS
A dry needling treatment was performed on trapezius trigger point number 2, and just after thar, a TENS curretn was applied. Patients will be reassed on fourth day after treatment.
Transcutaneous Nerve Stimulation.
Transcutaneous Nerve Stimulation (TENS) is a current used for pain treatment. The needle will be used as the negative pole and a adhesive patch 2 centimeters lateral will be the positive pole. The frecuency selected will have 2 Hz with pulses of 120 microseconds. The currente will be applied for 15 minutes.
Placebo
A placebo dry needling was performed on trapezius trigger point number 2. Patients will be reassed on fourth day after treatment.
Placebo needling
No active technique is performed with the placebo needling. Patient will be supine and a placebo needle willb be performed. The patient will remain supine for 15 minutes.
dry needling
A dry needling treatment was performed on trapezius trigger point number 2. Patients will be reassed on fourth day after treatment.
Dry needling
Dry needlin is a manual therapy technique used for miofascuial pain syndrom treatment. The patient will be supine, in a confortable position. The therapist localizes the trapezius trigger point number 2 and then performes the needling until 2 REL are obtenined. The patient will remain supine during 15 minutes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dry needling
Dry needlin is a manual therapy technique used for miofascuial pain syndrom treatment. The patient will be supine, in a confortable position. The therapist localizes the trapezius trigger point number 2 and then performes the needling until 2 REL are obtenined. The patient will remain supine during 15 minutes.
Transcutaneous Nerve Stimulation.
Transcutaneous Nerve Stimulation (TENS) is a current used for pain treatment. The needle will be used as the negative pole and a adhesive patch 2 centimeters lateral will be the positive pole. The frecuency selected will have 2 Hz with pulses of 120 microseconds. The currente will be applied for 15 minutes.
Placebo needling
No active technique is performed with the placebo needling. Patient will be supine and a placebo needle willb be performed. The patient will remain supine for 15 minutes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* VAS 2 or greather.
* Existance of miofascial trigger point in trapezius muscle assesed by an expert PT.
Exclusion Criteria
* Headache secondary to medular compression presenting one o the following signs: abnormal sensitivity, hiperreflexia, clonus, spread weakness, cervical hernia.
* Neck pain with radiculopathy.
* Whiplash.
* Vertebrobasilar syndrome.
* Dizzyness.
* Pregnancy.
* Having received dry needling treatment before.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad Rey Juan Carlos
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Josue Fernandez Carnero
PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jose Vicente León Hernández, PT
Role: PRINCIPAL_INVESTIGATOR
Universitdad Rey Juan Carlos
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidad Rey Juan Carlos
Alcorcón, Madrid, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
urjc20-13
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.